Capitol Health Limited

ASX:CAJ Voorraadrapport

Marktkapitalisatie: AU$383.6m

Capitol Health Beheer

Beheer criteriumcontroles 2/4

De CEO Capitol Health is Justin Walter, benoemd in Jul2019, heeft een ambtstermijn van 5.33 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 1.82M, bestaande uit 39.4% salaris en 60.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.44% van de aandelen van het bedrijf, ter waarde A$ 1.68M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.3 jaar en 5.3 jaar.

Belangrijke informatie

Justin Walter

Algemeen directeur

AU$1.8m

Totale compensatie

Percentage CEO-salaris39.4%
Dienstverband CEO5.3yrs
Eigendom CEO0.4%
Management gemiddelde ambtstermijn5.3yrs
Gemiddelde ambtstermijn bestuur5.3yrs

Recente managementupdates

Recent updates

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Jun 17
Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Jan 15
Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Dec 15
Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Oct 22
Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

May 28
Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Apr 16
Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05
Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14
Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19
Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22
Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01
Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17
Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25
Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04
Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Analyse CEO-vergoeding

Hoe is Justin Walter's beloning veranderd ten opzichte van Capitol Health's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024AU$2mAU$718k

-AU$15m

Mar 31 2024n/an/a

-AU$5m

Dec 31 2023n/an/a

AU$6m

Sep 30 2023n/an/a

-AU$3m

Jun 30 2023AU$2mAU$673k

-AU$12m

Mar 31 2023n/an/a

-AU$12m

Dec 31 2022n/an/a

-AU$12m

Sep 30 2022n/an/a

-AU$853k

Jun 30 2022AU$1mAU$670k

AU$11m

Mar 31 2022n/an/a

AU$12m

Dec 31 2021n/an/a

AU$14m

Sep 30 2021n/an/a

AU$13m

Jun 30 2021AU$2mAU$673k

AU$12m

Mar 31 2021n/an/a

AU$8m

Dec 31 2020n/an/a

AU$4m

Sep 30 2020n/an/a

AU$3m

Jun 30 2020AU$1mAU$592k

AU$865k

Mar 31 2020n/an/a

AU$8m

Dec 31 2019n/an/a

AU$15m

Sep 30 2019n/an/a

AU$20m

Jun 30 2019AU$390kAU$58k

AU$24m

Compensatie versus markt: De totale vergoeding ($USD 1.21M ) Justin } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 670.85K ).

Compensatie versus inkomsten: De vergoeding van Justin is gestegen terwijl het bedrijf verliesgevend is.

CEO

Justin Walter

5.3yrs

Tenure

AU$1,819,816

Compensatie

Mr. Justin Samuel Walter, BN (Hons), MPH (JCU), served as Director for Enlitic, Inc. since 2022. He has been the Chief Executive Officer, Managing Director and a Director at Capitol Health Limited since Ju...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Justin Walter
CEO, MD & Director5.3yrsAU$1.82m0.44%
A$ 1.7m
Brendon Pentland
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Melanie Leydin
Company Secretary7.3yrsgeen gegevensgeen gegevens

5.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van CAJ is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.3 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Justin Walter
CEO, MD & Director5.3yrsAU$1.82m0.44%
A$ 1.7m
Andrew Demetriou
Non-Executive Chairman10yrsAU$358.75k0.019%
A$ 72.0k
Laura McBain
Independent Non-Executive Director3.3yrsAU$130.63k0.011%
A$ 41.4k
Richard Loveridge
Independent Non-Executive Director7.2yrsAU$145.70k0.062%
A$ 236.3k
Kai-Chung Shaw
Independent Non-Executive Director3.2yrsAU$130.63kgeen gegevens

5.3yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van CAJ wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.3 jaar).